A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)
Clinical trial NCT03248492 · TERMINATED
Trial details
- NCT number
- NCT03248492
- Sponsor
- Daiichi Sankyo
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-25
- Primary completion
- 2019-03-21
- Enrollment
- 253
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.